Latest Posts › Biotechnology

Share:

GEN and FiercePharma Compile Lists of Top Selling Drugs for 2013

Earlier this month, Genetic Engineering & Biotechnology News released its list of the top 25 best-selling drugs worldwide for 2013. GEN's list, which the journal released on March 3 (see "The Top 25 Best-Selling Drugs of...more

3/27/2014 - Biotechnology Pharmaceutical Prescription Drugs

Biotech Venture Funding Rebounded in 2013 After Strong Fourth Quarter

Earlier this month, the National Venture Capital Association (NVCA), a trade association representing the U.S. venture capital industry, released the results of its MoneyTree Report on venture funding for 2013. The report,...more

1/27/2014 - Biotechnology Patents Pharmaceutical Venture Capital

More Q&A from Webinar on Top Patent Law Stories of 2013

On Tuesday, we presented a live webinar on the "Top Patent Law Stories of 2013." The webinar covered ten of the fourteen stories that made it onto Patent Docs seventh annual list of top biotech/pharma patent stories. Posts...more

1/24/2014 - 23andMe America Invents Act AMP v Myriad Biotechnology Bowman v Monsanto FTC v Actavis Innovation Act Life Sciences Monsanto Myriad Patent Infringement Patent Litigation Patent Reform Patent Trolls Patents Pharmaceutical SCOTUS

Top Three Stories of 2013

Reflecting upon the events of the past twelve months, Patent Docs presents its seventh annual list of top biotech/pharma patent stories. For 2013, we identified fourteen stories that were covered on Patent Docs last year...more

1/6/2014 - America Invents Act AMP v Myriad Biotechnology Bowman v Monsanto DNA First-to-File First-to-Invent Genetic Materials Genetically Engineered Seed Human Genes Inventors Monsanto Patent Infringement Patent Litigation Patent Reform Patents Pharmaceutical SCOTUS

Top Stories of 2013: #7 to #10

Reflecting upon the events of the past twelve months, Patent Docs presents its seventh annual list of top biotech/pharma patent stories. For 2013, we identified fourteen stories that were covered on Patent Docs last year...more

1/2/2014 - Ambry Biotechnology BRCA DNA Human Genes Life Sciences Myriad Patent Litigation Patents Pharmaceutical

Top Stories of 2013: #11 to #14

Reflecting upon the events of the past twelve months, Patent Docs presents its seventh annual list of top biotech/pharma patent stories. For 2013, we identified fourteen stories that were covered on Patent Docs last year...more

1/2/2014 - 23andMe Biosimilars Biotechnology BPCIA Medtronic v Boston Scientific Patents Pharmaceutical Unified Patent Court

Tufts Report Shows Dramatic Shift from Small Molecule to Biologic Drugs

Last week, the Tufts Center for the Study of Drug Development (CSDD) at Tufts University released a report showing that the pharmaceutical industry has dramatically shifted its focus from a historical concentration on small...more

11/20/2013 - Biotechnology Pharmaceutical Prescription Drugs

Bioethicists "Urge Maximal Transparency" in Response to 23andMe Patent

Last week, we discussed a patent, recently issued to 23andMe, Inc., that has created some controversy. The patent, U.S. Patent No. 8,543,339, is directed to a system for identifying a preferred gamete donor from among the...more

10/15/2013 - 23andMe Biotechnology Ethics Genetic Testing Human Genes Patents

23andMe Patent Creates Controversy

A patent issued to 23andMe, Inc. last month has created some controversy, and in response, the biotech company, based in Mountain View, California, has posted its side of the story on the 23andMe blog. The patent, U.S....more

10/9/2013 - 23andMe Biotechnology DNA Genetic Materials Human Genes Patent-Eligible Subject Matter Patents

Coalition Opposes Expansion of AIA ยง 18

Last week, a coalition of more than 100 companies and organizations including the Biotechnology Industry Organization (BIO), the California Healthcare Institute (CHI), and Eli Lilly & Company, sent a letter to Congressional...more

9/24/2013 - America Invents Act Biotechnology First-to-File First-to-Invent Patent Reform Patents

NEJM Perspective Calls for Recalibration of Bayh-Dole Act

In a perspective published in the August 29 issue of the New England Journal of Medicine, Dr. Howard Markel outlines the events leading up to the enactment of the Bayh-Dole Act and states that "a review of [the Act's] origins...more

9/11/2013 - Bayh-Dole Act Biotechnology Healthcare Professionals Proposed Amendments

Op-Eds in The Scientist Debate Impact of the AIA

Two Op-Eds appearing in The Scientist over the summer present competing views on the impact of the Leahy-Smith America Invents Act. In an article published in July, Dr. George Lewis, the Chief Scientific Officer and...more

9/6/2013 - America Invents Act Biotechnology First-to-File First-to-Invent Patent Reform Small Business

SkinMedica, Inc. v. Histogen Inc. (Fed. Cir. 2013)

On August 23, in SkinMedica, Inc. v. Histogen Inc., the Federal Circuit determined that the District Court for the Southern District of California did not err in construing the phrase "culturing . . . cells in...more

9/4/2013 - Biotechnology Infringement Patent Litigation Patents Pharmaceutical

BIO Reiterates Support for 12-Year Data Exclusivity Period for Biologics

Last month, in a letter to the U.S. Trade Representative, Ambassador Michael Froman, Biotechnology Industry Organization (BIO) President and CEO James Greenwood expressed support for the efforts of the Obama Administration to...more

8/21/2013 - Affordable Care Act Biologics Biotechnology Free Trade Agreement Pharmaceutical Prescription Drugs Trans-Pacific Partnership

Authors of Genome Medicine Article Form Genetic Testing Company

In a paper published in March in the journal Genome Medicine, Dr. Jeffrey Rosenfeld of the University of Medicine & Dentistry of New Jersey and Dr. Christopher Mason of Cornell University contended that due to the...more

8/13/2013 - Biotechnology DNA Genetic Materials Genetic Testing Genome Project Human Genes Medical Research Patents Pharmaceutical

Biotech Venture Funding Sees Second Quarter Rebound

Last week, the National Venture Capital Association (NVCA), a trade association representing the U.S. venture capital industry, released the results of its MoneyTree Report on venture funding for the second quarter of 2013. ...more

7/23/2013 - Biotechnology

Consortium Launches Public Database of BRCA Data

On June 13, the Genetic Alliance announced the launch of an initiative to fill the public information gap caused by the lack of available genetic information for the BRCA1 and BRCA2 genes. ...more

7/5/2013 - AMP v Myriad Biotechnology BRCA DNA Genetic Materials Genetic Services Genetic Testing Patents Pharmaceutical

Supreme Court Issues Decision in AMP v. Myriad -- Association for Molecular Pathology v. Myriad Genetics, Inc. (2013)

In a much anticipated decision, the Supreme Court issued its opinion this morning in Association for Molecular Pathology v. Myriad Genetics, Inc. In an opinion by Justice Thomas, joined by Chief Justice Roberts, Justices...more

6/14/2013 - AMP v Myriad Biotechnology DNA Human Genes Myriad Patent-Eligible Subject Matter Patents SCOTUS

Rubin v. General Hospital Corp. (Fed. Cir. 2013)

On March 28, the Federal Circuit in Rubin v. General Hospital Corp. affirmed judgment by the District Court for the District of Massachusetts dismissing the suit brought by Drs. Berish Rubin and Sylvia Anderson against The...more

5/8/2013 - Biotechnology Human Genes Inventors Patents

Biotech Venture Funding Down 33% in First Quarter

Earlier this month, the National Venture Capital Association (NVCA), a trade association representing the U.S. venture capital industry, released the results of its MoneyTree Report on venture funding for the first quarter of...more

5/1/2013 - Biotechnology Venture Capital Venture Funding

GEN Compiles List of Top Biopharma R&D Spenders

Earlier this month, Genetic Engineering & Biotechnology News published its list of the top 20 best-selling prescription drugs worldwide for 2012 (see "GEN Compiles List of Top Selling Drugs for 2012"). The biotech...more

3/21/2013 - Biopharmaceutical Biotechnology Patents Pharmaceutical Prescription Drugs Research Funding

Annual Venture Funding Drops for First Time in Three Years

Last month, the National Venture Capital Association (NVCA), a trade association representing the U.S. venture capital industry, released the results of its MoneyTree Report on venture funding for 2012. The report, which is...more

2/5/2013 - Biotechnology Medical Devices Startups Venture Capital Venture Funding

IPO Files Amicus Brief in Support of Respondents in Bowman v. Monsanto

In an amicus brief filed in support of respondents Monsanto Co. et al. late last week, the Intellectual Property Owners Association (IPO) urges the Supreme Court to find that the petitioner's replanting of commodity seed was...more

1/25/2013 - Biotechnology Commodity Seed Infringement Intellectual Property Owners Association Monsanto SCOTUS

Top Stories of 2012: #4 to #7

Reflecting upon the events of the past twelve months, Patent Docs presents its sixth annual list of top biotech/pharma patent stories. For 2012, we identified fifteen stories that were covered on Patent Docs last year that...more

1/3/2013 - Biotechnology DNA FDA Infringement Patent Exhaustion Patents Pharmaceutical Safe Harbors

Top Stories of 2012: #12 to #15

Reflecting upon the events of the past twelve months, Patent Docs presents its sixth annual list of top biotech/pharma patent stories. For 2012, we identified fifteen stories that were covered on Patent Docs last year that...more

1/2/2013 - America Invents Act Biotechnology Copyright Patent Reform Patents Pharmaceutical Request for Continued Examination

25 Results
|
View per page
Page: of 1